Metraipolis › archive › dc_db633fa664f5

Unveiling the potential of apigenin and kaempferol against colon cancer: an integrated network pharmacology and docking approach — Europe PMC PMID:41768980

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41768980
DOI
10.3389/fbinf.2026.1702572
License (as archived)
solo-consultazione
Archived
2026-11-05T20:47:26.733Z
SHA-256 of the archived text
fcc6d1b0539dde478bff80861160f1125ba3cfc42557a416a0bfb63a3de6c34e
Stable URL of this page
https://metraipolis.com/documento/dc_db633fa664f5

How to cite

Unveiling the potential of apigenin and kaempferol against colon cancer: an integrated network pharmacology and docking approach — Europe PMC PMID:41768980 — Europe PMC (en), https://europepmc.org/article/MED/41768980 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_db633fa664f5 (Metraipolis archive dc_db633fa664f5, sha256 fcc6d1b0539dde478bff80861160f1125ba3cfc42557a416a0bfb63a3de6c34e)
BibTeX
@misc{dcdb633fa664f5,
  title = {Unveiling the potential of apigenin and kaempferol against colon cancer: an integrated network pharmacology and docking approach — Europe PMC PMID:41768980},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41768980},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_db633fa664f5; sha256 fcc6d1b0539dde478bff80861160f1125ba3cfc42557a416a0bfb63a3de6c34e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41768980. Agents can read the archived copy with the MCP tool read_document.